Mounjaro 5 doses: the pen, the maths, and the myth worth correcting

The four-week myth: why people get the dose count wrong

The most common misconception about Mounjaro is that one pen equals four doses — one per week for a month. It is an easy mistake. Mounjaro is marketed and often priced in four-week blocks, packaging is sometimes described in monthly terms, and the whole rhythm of treatment is weekly. But the KwikPen itself contains five metered doses, not four.

Where does the confusion start? Partly in how pharmacies and services present pricing (a "monthly cost" can mean different things to different providers), and partly because some people conflate the titration schedule (which does move in roughly four-week steps) with the number of injections per pen. Those are two separate things. The titration schedule tells you when your prescriber might consider increasing your strength. The pen itself simply holds five doses, and once all five are used, the pen is finished and goes in a sharps container for safe disposal.

Knowing the real count matters practically. If you are planning ahead (say, ordering before a holiday) you can read more about why there are 5 doses in a Mounjaro pen and what that means for scheduling your supply. That is worth factoring in when you speak to your prescriber about timing. For a fuller picture of how Mounjaro's strengths and pen formats fit together, the guide to Mounjaro pen doses covers the detail.

What five doses per pen means for how Mounjaro is titrated

Mounjaro's UK licence covers six strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. Treatment begins at 2.5 mg (a strength whose job is to let your body adjust before any therapeutic effect is expected) and your prescriber will typically consider moving you up after four weeks at each level, if you are tolerating the current strength well. The NHS patient information for tirzepatide sets out the general principles of this escalation.

Because each pen holds five doses, a patient using a single pen at one strength will complete five weekly injections (roughly five weeks) before starting the next pen. In practice, prescribers at services like ours review your progress before approving a dose increase; it is not automatic. A real clinician reads your follow-up information; the decision is clinical, not algorithmic. If you want a clear answer to how many doses of Mounjaro you get and how they are structured across treatment, that page sets it out in full. If you are curious about what the 5 mg strength specifically involves, the Mounjaro 5 mg page goes into the evidence and considerations at that dose.

Side effects are most noticeable at the start of a new strength. The most commonly reported are gastrointestinal: nausea, loose stools, constipation, or an unsettled stomach. These tend to ease within the first week or two at each level for most people. Rarely, more serious effects can occur; any severe or persistent abdominal pain should be assessed medically without delay, and suspected side effects can be reported through the MHRA's Yellow Card scheme.

Doses in practice: storage, injection sites, and the five-week window

The five doses inside a KwikPen are accessed one by one, each separated by seven days. You do not need to count out a volume or adjust a dial, the pen delivers a fixed, pre-set amount each time, and if you want to understand exactly what that looks like in practice, the page on Mounjaro doses in ml explains the volumes being delivered at each strength. Injection sites rotate between the abdomen, thigh, and upper arm; using the same spot repeatedly can affect how the medicine is absorbed. If you want to understand how the full range of Mounjaro doses works across the six available strengths, that guide covers each one in detail alongside what the pen is actually delivering.

Storage matters. Mounjaro should be kept in the fridge at 2–8 °C. There is a limited window during which the pen can be kept at room temperature once removed, the exact duration is in the Patient Information Leaflet and the SmPC, and that is where you should check it rather than relying on informal sources. A practical tip: many people keep the pen in the fridge door, where it is easy to spot but protected from freezing at the back.

Because Mounjaro is a Black Triangle (▼) medicine, it carries additional monitoring requirements from the MHRA. That does not mean it is unsafe to use, it means the regulators want healthcare professionals and patients to report any new or unexpected effects so the picture stays current. The monitoring infrastructure is one reason clinical oversight matters throughout treatment, not just at the start.

Getting access through a private route

Mounjaro is a prescription-only medicine in the UK. A prescriber (not a website form, not an automated system) must assess whether it is appropriate for you. Through nume's free consultation, a GPhC-registered Independent Prescriber reviews your information the same day; if you are clinically suitable, treatment is dispatched the same day for free next-working-day delivery via DPD. The about us page explains the pharmacy and clinical team behind that process.

Private eligibility broadly follows the licensed criteria: adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition such as raised blood pressure, high cholesterol, or type 2 diabetes. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance. BMI alone does not determine suitability, the prescriber considers your full health picture. For a broader look at the cost side of private treatment, the weight-loss treatment overview provides honest context on what a private prescription includes. If you are weighing up whether private treatment makes sense, that is a good starting point before booking a consultation.